Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma Other Refereed Contribution to Refereed Journals uri icon

Overview

Published in

  • Bone Marrow Transplantation

Time

Date/time value

  • 2011

Identity

Digital Object Identifier (DOI)

  • 10.1038/bmt.2010.180

Additional Document Info

Parent Title

  • Bone Marrow Transplantation

Volume

  • 46

Issue

  • 5

Publisher

  • Nature Publishing Group